Global healthcare AI company Dencom (CEO Byung-Jun Lim) announced on the 19th that it has established a local corporation, 'AIzac AI Inc.' in Delaware, USA, and will begin full-scale global business expansion, focusing on the North American market.
AIzac AI Inc., a U.S. corporation established with 100% investment from Dencom, specializes in developing and supplying AI-based voice recognition dental solutions, and through the establishment of this North American corporation, plans to accelerate the introduction of AI technology in the U.S. dental market and expand its position in the global market.
Dencom developed 'Densper™', an AI voice recognition engine specialized in the dental field. Using this, it provides 'Voice Charting', which automatically records the doctor's voice during treatment as medical records, a multilingual consultation function that supports simultaneous interpretation for foreign patients, and 'Voice Viewer Controller', which allows doctors to control dental medical images such as computed tomography (CT) with their voice.
Densper™ combines dental-specific voice data learning and natural language processing technology to provide high-level voice recognition capabilities in the dental field. Its voice-to-text (STT) accuracy is over 99%, and it supports multiple languages, including Korean, English, and French.
Dencom is also preparing customized services that take into account the characteristics of the US market. The US dental market operates as a network system, with as few as 150 and as many as 3,000 hospitals operating integrated medical systems through a single head office. Dencom plans to provide solutions tailored to these market characteristics.
In particular, Dencom, which confirmed the marketability and applicability of AI-based dental voice recognition solutions by participating in the 2024 New York Dental Exhibition 'GNYDM (Greater New York Dental Meeting)' and signing strategic partnerships with several overseas companies, plans to increase its market penetration rate by strengthening local marketing in the US and expanding partnerships through the establishment of this corporation.
Lim Byeong-jun, CEO of Dencom, said, “AI-based voice recognition technology is a key solution that can dramatically improve the efficiency and accuracy of dental treatment,” and added, “Having confirmed the need for AI voice recognition technology through our participation in the 2024 GNYDM, we will establish ourselves as a rapidly growing healthcare AI company in the North American and global markets through the establishment of this corporation.”
Meanwhile, Dencom, Korea’s only dental voice AI solution company established in 2017, has attracted 10 billion won in Series A2 investment with participation from Starset Investment, DSC Investment, and TS Investment. Dencom aims to maximize the efficiency and accuracy of dental treatment through AI voice recognition technology and lead the digital innovation of the global dental market. The establishment of this US corporation is expected to accelerate Dencom’s entry into the global healthcare AI market.
- See more related articles
You must be logged in to post a comment.